757 related articles for article (PubMed ID: 20006471)
1. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
[TBL] [Abstract][Full Text] [Related]
2. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections.
Falagas ME; Rafailidis PI; Kasiakou SK; Hatzopoulou P; Michalopoulos A
Clin Microbiol Infect; 2006 Dec; 12(12):1227-30. PubMed ID: 17121631
[TBL] [Abstract][Full Text] [Related]
5. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of colistin: prospective comparative cohort study.
Paul M; Bishara J; Levcovich A; Chowers M; Goldberg E; Singer P; Lev S; Leon P; Raskin M; Yahav D; Leibovici L
J Antimicrob Chemother; 2010 May; 65(5):1019-27. PubMed ID: 20299494
[TBL] [Abstract][Full Text] [Related]
7. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
9. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
10. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
[TBL] [Abstract][Full Text] [Related]
11. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
[TBL] [Abstract][Full Text] [Related]
12. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
14. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Gram-negative infections: the use of colistin.
Michalopoulos AS; Karatza DC
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
20. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction.
Turkoglu M; Dizbay M; Ciftçi A; Aksakal FN; Aygencel G
Int J Antimicrob Agents; 2012 Feb; 39(2):142-5. PubMed ID: 22115538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
